The invention concerns a pharmaceutical composition characterized in that it contains a combination of a parasym-patholytic agent, a sympathomimetic agent and a contact anesthetic. Such a composition can be injected into the anterior chamber of the eye prior to a cataract procedure or instilled on the eye prior to a laser treatment.